Retatrutide5mgPackaging illustration
Ingredient identity
FOXO4-DRI is a modified peptide construct identified by the DRI designation. The modification is central to its identity, so the sequence and stereochemical form should accompany the quoted vial specification.
Reading the specification
- Catalog specifications for FOXO4-DRI: 10mg. Each specification has its own product code. Quantities are counted in boxes of 10 vials; the specification describes the contents of one vial.
Storage & handling documentation
Check the container label, batch number and seal on receipt. Follow the storage conditions, expiry date and handling instructions documented for that specific batch. Request the SDS and storage documentation before opening; do not assume a universal temperature or shelf life for different materials.
What to confirm when ordering
Confirm the exact peptide identity and declared content for the selected SKU. Request the corresponding batch COA and distinguish purity results from the amount of material in each vial.
Specification reference
| Product code | Declared vial specification | Pack specification | USD / box · 10 vials per box |
|---|---|---|---|
| F4-10mg | 10mg | 10mg × 10 vials | USD 199.00 |
The table lists procurement specifications. A batch COA records the measurements for the supplied batch.
Supply & packaging
Wholesale starts from one box of 10 vials. We provide factory-direct quotations and support custom caps, labels and packaging.
Choose your specification and number of boxes, then include any artwork, destination and document requirements in your inquiry.
Batch COA & independent testing
Every product is supplied with a COA from batch sampling. The report must correspond to the product and batch supplied.
You may choose an independent third-party laboratory for testing.
If testing confirms that content does not meet the agreed specification, we support a full refund.
Read our quality commitment